Agomab Therapeutics NV AGMB

Latest FY: 2025 Healthcare Biotechnology
Market Price $14.82
Market Cap $506.70M
P/E Ratio N/A
Quick Peer Compare (Healthcare):
Revenue (FY 2025) ↓-98.2% YoY
$42.00K
3-Yr CAGR: 18.9%
Net Income ↓-35.2% YoY
-$62.55M
Net Margin: -148,921.4%
Free Cash Flow
N/A
FCF Yield: N/A
EPS (Diluted)
N/A
Basic: N/A
Return on Equity Efficiency
-507.1%
ROA: -40.7%

📊 Multi-Year Historical Performance & Trends

Financial Performance History Revenue, Net Income & Free Cash Flow
Margins Trend (%) Gross, Operating & Net Margins
Balance Sheet Strength Cash, Debt & Equity
Cash Flow Generation Operating Cash Flow vs CapEx vs FCF

📈 Year-over-Year (YoY) Growth History (AGMB)

All monetary values in millions ($M)
⚠️ YoY Data Quality Alert
  • FY 2017: Revenue YoY (-38.7%) is identical to Gross Profit YoY (-38.7%). Verify the underlying Revenue and Gross Profit values for FY 2017 and FY 2016.
  • FY 2018: Revenue YoY (-52.2%) is identical to Gross Profit YoY (-52.2%). Verify the underlying Revenue and Gross Profit values for FY 2018 and FY 2017.
  • FY 2022: Revenue YoY (-99.8%) is identical to Gross Profit YoY (-99.8%). Verify the underlying Revenue and Gross Profit values for FY 2022 and FY 2021.
Fiscal Year Revenue Revenue YoY Gross Profit Net Income Net Inc YoY Diluted EPS EPS YoY Div / Sh Div Yield Op. Cash Flow Free Cash Flow FCF YoY
FY 2016 $0.4M $0.4M
FY 2017 $0.2M -38.7% $0.2M
FY 2018 $0.1M -52.2% $0.1M
FY 2019
FY 2020
FY 2021 $15.2M $15.2M
FY 2022 $0.0M -99.8% $0.0M $-8.1M
FY 2023 -100.0% $-11.4M -39.9%
FY 2024 $2.3M $2.2M $-46.3M -306.2%
FY 2025 $0.0M -98.2% $0.0M $-62.5M -35.2%
$

Valuation

Market Price $14.82
Market Cap $506.70M
Enterprise Value $422.54M
P/E Ratio N/A
P/B Ratio 41.07
FCF Yield N/A
Dividend Yield 0.00%
Shares Outstanding 34,167,168
%

Profitability & Margins

Gross Margin 41.18%
Operating Margin -11,564.29%
Net Margin -148,921.43%
Return on Equity (ROE) -507.11%
Return on Assets (ROA) -40.69%
Asset Turnover 0.00x
Revenue 3-Yr CAGR 18.88%
🛡️

Financial Health & Liquidity

Current Ratio 6.52
Cash Ratio 4.65
Debt / Equity 0.183
Debt / Assets 0.015
Cash & Equivalents $86.42M
Total Debt $2.26M
Book Value / Share $0.36
💧

Cash Flow Efficiency

Operating Cash Flow N/A
Capital Expenditures (CapEx) $4.00K
Free Cash Flow N/A
OCF / Revenue N/A
FCF / Revenue N/A
FCF 3-Yr CAGR N/A
🏷️

Per Share Metrics

EPS (Diluted) N/A
EPS (Basic) N/A
Dividends / Share N/A
Book Value / Share $0.36
EPS YoY Growth N/A
🏛️

Balance Sheet (FY 2025)

Total Assets $153.71M
Total Liabilities $141.37M
Stockholders' Equity $12.33M
Current Assets $121.24M
Current Liabilities $18.59M